
Brenda Libby Coleman
Examiner (ID: 16325, Phone: (571)272-0665 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 2611, 1624, 1611 |
| Total Applications | 3154 |
| Issued Applications | 1970 |
| Pending Applications | 485 |
| Abandoned Applications | 741 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6033485
[patent_doc_number] => 20020019389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Urea derivative useful as an anti-cancer agent and process for preparing same'
[patent_app_type] => new
[patent_app_number] => 09/880823
[patent_app_country] => US
[patent_app_date] => 2001-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22093
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019389.pdf
[firstpage_image] =>[orig_patent_app_number] => 09880823
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/880823 | Urea derivative useful as an anti-cancer agent and process for preparing same | Jun 13, 2001 | Abandoned |
Array
(
[id] => 6851972
[patent_doc_number] => 20030144175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-31
[patent_title] => 'Protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 09/881334
[patent_app_country] => US
[patent_app_date] => 2001-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 91766
[patent_no_of_claims] => 61
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0144/20030144175.pdf
[firstpage_image] =>[orig_patent_app_number] => 09881334
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/881334 | Protease inhibitors | Jun 13, 2001 | Abandoned |
Array
(
[id] => 1348446
[patent_doc_number] => 06579870
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-06-17
[patent_title] => 'Bis-arylsulfones'
[patent_app_type] => B2
[patent_app_number] => 09/877308
[patent_app_country] => US
[patent_app_date] => 2001-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14159
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/579/06579870.pdf
[firstpage_image] =>[orig_patent_app_number] => 09877308
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/877308 | Bis-arylsulfones | Jun 7, 2001 | Issued |
Array
(
[id] => 6405367
[patent_doc_number] => 20020037560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-03-28
[patent_title] => 'Bicyclic terpenes and synthesis thereof'
[patent_app_type] => new
[patent_app_number] => 09/876169
[patent_app_country] => US
[patent_app_date] => 2001-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 6008
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0037/20020037560.pdf
[firstpage_image] =>[orig_patent_app_number] => 09876169
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/876169 | Bicyclic terpenes and synthesis thereof | Jun 7, 2001 | Abandoned |
Array
(
[id] => 773799
[patent_doc_number] => 07001902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-02-21
[patent_title] => '4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/276822
[patent_app_country] => US
[patent_app_date] => 2001-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4294
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/001/07001902.pdf
[firstpage_image] =>[orig_patent_app_number] => 10276822
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/276822 | 4-(2 phenylthiazol-5-yl)-1, 4-diazabicyclo-[3.2.2]nonane derivatives, preparation and therapeutic use thereof | May 28, 2001 | Issued |
Array
(
[id] => 1349711
[patent_doc_number] => 06583280
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-06-24
[patent_title] => 'Polyamine analogues having antiproliferative activity'
[patent_app_type] => B1
[patent_app_number] => 09/864868
[patent_app_country] => US
[patent_app_date] => 2001-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3700
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/583/06583280.pdf
[firstpage_image] =>[orig_patent_app_number] => 09864868
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/864868 | Polyamine analogues having antiproliferative activity | May 24, 2001 | Issued |
Array
(
[id] => 1595182
[patent_doc_number] => 06384029
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-05-07
[patent_title] => 'Optically active pyridyl-4h-1,2,4-oxdadiazine derivative and its use in the treatment of vascular diseases'
[patent_app_type] => B1
[patent_app_number] => 09/762949
[patent_app_country] => US
[patent_app_date] => 2001-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3634
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/384/06384029.pdf
[firstpage_image] =>[orig_patent_app_number] => 09762949
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/762949 | Optically active pyridyl-4h-1,2,4-oxdadiazine derivative and its use in the treatment of vascular diseases | May 14, 2001 | Issued |
Array
(
[id] => 5802261
[patent_doc_number] => 20020010186
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-24
[patent_title] => 'Dihydropyrimidines and uses thereof'
[patent_app_type] => new
[patent_app_number] => 09/855597
[patent_app_country] => US
[patent_app_date] => 2001-05-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 67712
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0010/20020010186.pdf
[firstpage_image] =>[orig_patent_app_number] => 09855597
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/855597 | Dihydropyrimidines and uses thereof | May 14, 2001 | Abandoned |
Array
(
[id] => 1383253
[patent_doc_number] => 06555681
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-04-29
[patent_title] => 'Process for preparing cross-bridged tetraaza macrocycles'
[patent_app_type] => B1
[patent_app_number] => 09/831788
[patent_app_country] => US
[patent_app_date] => 2001-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2032
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/555/06555681.pdf
[firstpage_image] =>[orig_patent_app_number] => 09831788
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/831788 | Process for preparing cross-bridged tetraaza macrocycles | May 13, 2001 | Issued |
Array
(
[id] => 5874922
[patent_doc_number] => 20020049241
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-25
[patent_title] => 'Conformationally rigid bicyclic and adamantane derivatives useful as alpha2-adrenergic blocking agents'
[patent_app_type] => new
[patent_app_number] => 09/846399
[patent_app_country] => US
[patent_app_date] => 2001-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7514
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0049/20020049241.pdf
[firstpage_image] =>[orig_patent_app_number] => 09846399
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/846399 | Conformationally rigid bicyclic and adamantane derivatives useful as 2-adrenergic blocking agents | Apr 30, 2001 | Issued |
Array
(
[id] => 6477046
[patent_doc_number] => 20020022619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-21
[patent_title] => 'Tricyclic fused pyridine and pyrimidine derivatives as CRF antagonists'
[patent_app_type] => new
[patent_app_number] => 09/845867
[patent_app_country] => US
[patent_app_date] => 2001-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6847
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0022/20020022619.pdf
[firstpage_image] =>[orig_patent_app_number] => 09845867
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/845867 | Tricyclic fused pyridine and pyrimidine derivatives as CRF antagonists | Apr 29, 2001 | Abandoned |
Array
(
[id] => 1050140
[patent_doc_number] => 06861419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-03-01
[patent_title] => 'Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof'
[patent_app_type] => utility
[patent_app_number] => 09/836548
[patent_app_country] => US
[patent_app_date] => 2001-04-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31685
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/861/06861419.pdf
[firstpage_image] =>[orig_patent_app_number] => 09836548
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/836548 | Substituted 1, 4-thiazepine and analogs as activators of caspases and inducers of apoptosis and the use thereof | Apr 17, 2001 | Issued |
| 09/807599 | NITROGEN-CONTAINING CONDENSED HETEROCYCLIC DERIVATIVES, THEIR PRODUCTION AND AGENT | Apr 12, 2001 | Abandoned |
Array
(
[id] => 6033481
[patent_doc_number] => 20020019388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-14
[patent_title] => 'Diazabicyclic central nervous system active agents'
[patent_app_type] => new
[patent_app_number] => 09/833914
[patent_app_country] => US
[patent_app_date] => 2001-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65781
[patent_no_of_claims] => 79
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0019/20020019388.pdf
[firstpage_image] =>[orig_patent_app_number] => 09833914
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/833914 | Diazabicyclic central nervous system active agents | Apr 11, 2001 | Issued |
Array
(
[id] => 5952261
[patent_doc_number] => 20020007057
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-17
[patent_title] => 'Methods of making cross-bridged macropolycycles'
[patent_app_type] => new
[patent_app_number] => 09/832579
[patent_app_country] => US
[patent_app_date] => 2001-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10034
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0007/20020007057.pdf
[firstpage_image] =>[orig_patent_app_number] => 09832579
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/832579 | Methods of making cross-bridged macropolycycles | Apr 10, 2001 | Issued |
Array
(
[id] => 1401045
[patent_doc_number] => 06537989
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-03-25
[patent_title] => 'Azadioxacycloalkene derivatives, methods for the production thereof and their use as fungicides and pest control agents'
[patent_app_type] => B1
[patent_app_number] => 09/806608
[patent_app_country] => US
[patent_app_date] => 2001-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20510
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 427
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/537/06537989.pdf
[firstpage_image] =>[orig_patent_app_number] => 09806608
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/806608 | Azadioxacycloalkene derivatives, methods for the production thereof and their use as fungicides and pest control agents | Apr 1, 2001 | Issued |
Array
(
[id] => 1508508
[patent_doc_number] => 06441165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-08-27
[patent_title] => 'Process for the preparation of 11-amino-3-chloro-6, 11-dihydro-5, 5-dioxo-6-methyl-dibenzoc,f1,2thiazepine and application to the synthesis of tianeptine'
[patent_app_type] => B2
[patent_app_number] => 09/821221
[patent_app_country] => US
[patent_app_date] => 2001-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1329
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/441/06441165.pdf
[firstpage_image] =>[orig_patent_app_number] => 09821221
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/821221 | Process for the preparation of 11-amino-3-chloro-6, 11-dihydro-5, 5-dioxo-6-methyl-dibenzoc,f1,2thiazepine and application to the synthesis of tianeptine | Mar 28, 2001 | Issued |
Array
(
[id] => 6243165
[patent_doc_number] => 20020045619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-04-18
[patent_title] => '4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents'
[patent_app_type] => new
[patent_app_number] => 09/808836
[patent_app_country] => US
[patent_app_date] => 2001-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13790
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20020045619.pdf
[firstpage_image] =>[orig_patent_app_number] => 09808836
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/808836 | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents | Mar 14, 2001 | Issued |
Array
(
[id] => 1189454
[patent_doc_number] => 06734301
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-11
[patent_title] => '2,3,4,5-Tetrahydro-1H-1,4diazepino1,7-aindole compounds'
[patent_app_type] => B2
[patent_app_number] => 09/803242
[patent_app_country] => US
[patent_app_date] => 2001-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46165
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/734/06734301.pdf
[firstpage_image] =>[orig_patent_app_number] => 09803242
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/803242 | 2,3,4,5-Tetrahydro-1H-1,4diazepino1,7-aindole compounds | Mar 7, 2001 | Issued |
Array
(
[id] => 7136718
[patent_doc_number] => 20040044201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-04
[patent_title] => 'Protease inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/239343
[patent_app_country] => US
[patent_app_date] => 2002-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41817
[patent_no_of_claims] => 104
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20040044201.pdf
[firstpage_image] =>[orig_patent_app_number] => 10239343
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/239343 | Protease inhibitors | Mar 6, 2001 | Issued |